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Abstract
The time course of interaction of caldesmon with actin may be monitored by fluorescence changes
that occur upon the binding of 12-(N-methyl-N-(7-nitrobenz-2-oxa-l,3-diazol-4-yl))-labeled
caldesmon to actin or to acrylodan actin. The concentration dependence of the observed rate of
caldesmon-actin binding was analyzed to a first approximation as a single-step reaction using a Monte
Carlo simulation. The derived association and dissociation rates were 107 M−1 s−1 and 18.2 s−1,
respectively. Smooth muscle tropomyosin enhances the binding of caldesmon to actin, and this was
found to be due to a reduction in the rate of dissociation to 6.3 s −1. There is no evidence from this
study for a different mechanism of binding in the presence of tropomyosin. The fluorescence changes
that occurred with the binding of 12-(N-methyl-N-(7-nitrobenz-2-oxa-l,3-diazol-4-yl))-labeled
caldesmon to actin or actin-tropomyosin were reversed by the addition of myosin subfragment 1 as
predicted by a competitive binding mechanism.
The protein caldesmon inhibits the stimulation of myosin ATPase activity by actin (Dabrowska
et al., 1985; Smith and Marston, 1985; Ngai and Walsh, 1985; Sobue et al., 1985). Caldesmon
also inhibits force production when added to smooth muscle fibers (Pfitzer et al., 1993) and to
skeletal muscle fibers, which normally lack caldesmon (Brenner et al., 1991). Several studies
indicate that caldesmon has the potential to modulate contractility (Yamashiro et al., 1990;
Walker et al., 1989; Hegmann et al., 1991; Katsuyama et al., 1992) although its primary role
as a regulatory protein is not yet proven.
We have proposed that an important aspect of the inhibition of ATPase activity by caldesmon
is the inhibition of binding of myosin subfragment 1 (S1)1 to actin in both the presence and
absence of tropomyosin (Chalovich et al., 1987;Hemric and Chalovich, 1988;Velaz et al.,
1989;Velaz et al, 1990;Chen and Chalovich, 1992). This view is not universally accepted, and
other reports suggest that in the presence of tropomyosin and under conditions where S1
concentrations are high relative to caldesmon, inhibition of ATPase activity occurs with little
reduction of Sl-ATP binding (Marston and Redwood, 1993). This latter model requires that
the mode of action of caldesmon be quite different in the presence of tropomyosin.
Testing the different models of caldesmon both by mathematical modeling and by
experimentation requires information regarding the rates of binding of caldesmon to actin in
the presence and absence of tropomyosin. We have used two combinations of fluorescent
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probes to measure the concentration dependence of this association reaction. The concentration
dependence of the observed association rates was analyzed by a simple Monte Carlo model
assuming that the binding is a single-step mechanism.
EXPERIMENTAL PROCEDURES
Proteins
Smooth muscle tropomyosin was isolated from turkey gizzards either by the method of
Bretscher (1984) or by a modification of the method of Graceffa (1992), which avoids heat
treatment of the tropomyosin. Other proteins were prepared as described earlier (Chalovich et
al., 1992).
For modification with IANBD, caldesmon was treated with 10 mM dithiothreitol for 30 min
at 37 °C and then loaded onto a 1.5 × 15-cm column of ACA 202 (Spectrum) gel filtration
resin equilibrated with 100 mM KCl, 50 mM Tris-HCl, pH 7.5, 1 mM EDTA. To the mixture was
added a stock of 25 mM IANBD in dimethyl formamide to give a concentration 5 times that of
the caldesmon concentration. The reaction was stopped by the addition of dithiothreitol to 1
mM after an incubation of 4 h at 18 °C. Unreacted probe was removed by gel filtration
chromatography on ACA 202 resin. The extent of labeling was determined to be between 1.5
and 2 mol of probe/mol of caldesmon using an extinction coefficient of 2.6 × 104 M1 cm−1 at
495 nm (Trayer and Trayer, 1988). Actin was labeled with acrylodan at Cys374 by incubating
at 4 °C for 12 h in a solution containing 0.1 M NaCl, 10 mM Tris-HCl, pH 7.5, 2 mM MgCl2, and
1 mM NaN3 with a 5-fold molar excess of acrylodan. The extent of labeling was 70–100% as
determined using an extinction coefficient of 1.29 × 104 M−1 cm−1 at 360 nm (Prendergast et
al., 1983).
To determine the location of the fluorescent probe, NBD-labeled caldesmon was digested with
chymotrypsin (1:1000, w/w) for 5 min, and the products of reaction were analyzed by high
pressure liquid chromatography on an SP-R cation exchange column (Waters) or by SDS-
polyacrylamide gel electrophoresis. Polypeptides that had been previously determined to
originate from the NH2-terminal myosin binding region (Velaz et al., 1990) and the COOH-
terminal actin binding region (Chalovich et al., 1992) were fluorescently labeled. In
preparations that were not completely labeled, the myosin binding fragment was more
fluorescent than the actin binding fragments, suggesting a more rapid reaction of the probe
with the former site. In another approach, the digested IANBD-labeled caldesmon was applied
to a 1.5 × 9-cm calmodulin affinity column equilibrated with 5 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 1 mM MgCl2. The fluorescently labeled myosin binding fragment was in the breakthrough
volume and was purified further as described earlier (Velaz et al., 1990). Intact caldesmon and
the 35-kDa, 20-kDa, and smaller actin and calmodulin binding fragments were eluted by
replacing the buffer with one containing 1 mM EGTA in place of the CaCl2. The 35- and 20-
kDa actin binding fragments were purified as described previously (Chalovich et al., 1992).
Protein concentrations were determined by absorbance at 280 nm except for caldesmon, which
was determined by the Lowry assay using bovine serum albumin as a standard. We have shown
earlier that the Lowry assay gives an excellent estimate of the true caldesmon concentration
(Velaz et al., 1989). The molecular weights used for calculation of protein concentrations were
120,000 (S1), 42,000 (actin), 68,000 (tropomyosin), 16,500 (calmodulin), 87,000 (caldesmon),
and 20,000 (the actin binding fragments of caldesmon).
ATPase Assays
The ATPase activity of skeletal S1 was measured by the liberation of 32Pi from [32Pi]ATP as
described earlier (Chalovich and Eisenberg, 1982).
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Sequence Analysis
Partially purified polypeptides were run on SDS-10% polyacrylamide gels and
electrophoretically transferred to Bio-Rad sequential grade polyvinylidene difluoride
membrane. The fluorescent band was cut out of the membrane and sequenced at the UCLA
Protein Microsequencing Facility.
Electron Microscopy
Samples were prepared by the drop method (Hayat, 1972) and negatively stained with 1%
uranyl acetate. Samples were examined with a JEOL 1200EX electron microscope at 65 kV.
Steady State Fluorescence Measurements
Fluorescence was measured on a SPEX Fluorolog 2 spectrofluorometer in 0.4 x 1.0-mm cells
at 15 °C. The excitation and emission slit widths were 1.25 mm (4.5-nm band-pass). Binding
isotherms were constructed by maintaining the actin concentration at 1 or 2 μm and varying
the caldesmon concentration. Results were most easily interpreted when the fluorescence of
the actin probe was monitored so that the signal was proportional to the number of actin sites
occupied. Curves of the fraction of caldesmon bound/total actin, or θ, versus free caldesmon
were constructed by assuming that when the fluorescence no longer changed the actin was
saturated. The free caldesmon concentration was calculated using the analysis of McGhee and
von Hippel (1974) assuming different values of stoichiometry (n), isolated site binding constant
(K), and cooperativity parameter (ω). These parameters were varied until there was a
satisfactory fit to the experimental data. There is not a unique solution to such fluorescence
titration data when the stoichiometry is unknown. The stoichiometry of binding is known to
be 1 caldesmon per 7 (Velaz et al, 1989) or more (Smith et al, 1987) actin monomers; a value
of 7 was used in the calculations. The MLAB program was used in this mathematical modeling.
Stopped Flow Kinetic Studies
Measurements were made in 10 mM imidazole, pH 7.0, 2 mM MgCl2, 34 mM potassium
propionate, 1 mM EGTA, and 1 mM dithiothreitol buffer, using an Applied Photophysics
DX17.MV/2 sequential stopped flow spectrofluorometer. The binding of caldesmon to actin
was monitored as an increase in light scattering, an increase in fluorescence intensity of the
NBD probe on caldesmon, or a decrease in fluorescence of acrylodan-labeled actin upon
binding to IANBD-modified caldesmon. IANBD fluorescence was monitored using a filter
with 0% transmission at 510 nm and 80% transmission at 540 nm with excitation at 492 nm.
Acrylodan fluorescence was monitored with excitation at 391 nm with a filter having 0%
transmission at 430 nm and 80% transmission at 500 nm or with a 485–494-nm band-pass
filter; both filters produced the same rate constant, but the 500-nm cut-on filter produced the
larger signal.
The concentration of caldesmon used was at least 10 times the concentration of binding sites,
assuming one caldesmon binds to at least seven actin monomers. Two precautions were used
to avoid actin depolymerization in cases where very low actin concentrations were used. Actin
was diluted from a 20 μM stock and used for kinetic measurements within 5 min so that
appreciable depolymerization would not occur. The same results were obtained using a final
actin concentration of 0.5 μM or 2 μM. Alternatively, the actin was treated with a 1.2-fold molar
excess of phalloidin added from a 10 mM stock in methanol. Identical results were obtained in
the presence and absence of phalloidin. Cytochalasin D (1 mol/100 mol of actin monomer)
was sometimes added to the actin when high actin concentrations were used to facilitate mixing.
We detected no difference in the traces obtained in the presence and absence of cytochalasin
D.
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Association rates were measured by mixing IANBD-labeled caldesmon with actin or
acrylodan-labeled actin in either the presence or absence of tropomyosin. Averages of up to
15 kinetic measurements were analyzed by fitting equations for a monoexponential or
biexponential process to the data with the software provided in the Applied Photophysics
package. Caldesmon binds to an actin lattice where a single binding site consists of several
actin monomers. In such situations there is a parking problem, that is units consisting of seven
free actin monomers are not always available, so binding of caldesmon may require
reorganization of existing bound caldesmon molecules. The result is that second order rate
constants of the association reaction cannot simply be obtained from the slope of &kobs against
free ligand concentration. We therefore analyzed the kinetic data by a Monte Carlo simulation.
The binding and dissociation between a caldesmon molecule and a 7-mer actin are assumed to
be simple one-step reactions with rate constants k and k′, respectively. The equilibrium constant
for the reaction is defined as K = k/k′. Because the value of K can be obtained from equilibrium
binding measurements, only one of the rate constants is an adjustable parameter. We assumed
that the actins in solution are uniform in length, with M monomers per actin filament. M and
k (or k′) are the only adjustable parameters in our simulation.
The simulation of the kinetics of binding of caldesmon to actin was carried out by following
the transitions of a single actin filament among its various “states” as a function of time, starting
from a bare actin filament at time 0. An actin state is specified not only by the number of bound
caldesmon molecules but also by the distribution of the gaps between two neighboring
caldesmons. The transition between any two actin states always involves either a binding or a
dissociation reaction. Analyses of the equilibrium binding of caldesmon to actin by the equation
of McGhee and von Hippel (1974) show that there is a small amount of positive cooperativity,
which compensates for the parking problem (Velaz et al., 1989). We neglect this cooperativity
between bound caldesmon molecules in this initial kinetic analysis. Because the cooperativity
is small, this is a good first approximation (we are working on a more complete model that
accounts for the cooperativity). Thus, if the transition between two states involves the binding
of a caldesmon to a gap of m empty units between two bound caldesmon molecules on actin,
the transition probability can be evaluated as follows: α = (m -6)kCc, where Cc is the
concentration of caldesmon in solution. Note that m must be larger than 7 for binding to occur.
If the transition involves the desorption of a caldesmon from the actin, the transition probability
is simply equal to k′ The number of caldesmon molecules in solution changes when caldesmon
binds to (or dissociates from) actin; this causes the caldesmon concentration in solution to
change as a function of time during the simulation. The concentration of caldesmon in solution
at any given time can be evaluated using the following equation: Cc = Cc° - (n/M)Cα°, where
n is the number of total bound caldesmon molecules on the single actin filament and Cα° and
Cc° are the initial concentrations of actin monomers and caldesmon molecules, respectively,
as prepared in the experiment at time 0.
At any given state, all of the “out-going” transition probabilities can be evaluated and used to
calculate the average “occupation time” that the actin will stay in that state as well as to
determine which state the system will go to when the next transition occurs. Thus, by following
a path of state transitions, a histogram of the total bound caldesmon on actin can be obtained
as a function of time (see Fig. 1). A large number of similar histograms were obtained by
repeating the simulation with the same set of parameters. The kinetic curve of caldesmon
binding was then obtained by averaging over these histograms.
RESULTS
Light-scattering measurements were not useful for the measurement of unmodified caldesmon
binding to actin because the initial binding reaction had a very small signal, while the
subsequent slow bundling of actin filaments (caused by the large excess of caldesmon over
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actin) produced a very large signal. The slow reaction, which was completed in about 20 min,
was confirmed as actin filament bundling by electron microscopy (not shown). Large signals
were obtained with the binding of NBD-labeled caldesmon to either acrylodan-labeled actin
or to native actin. In the former case, the actin probe was observed, while in the latter case
caldesmon fluorescence was monitored.
Fig. 2A (curves 1 and 3) shows that the binding of NBD-labeled caldesmon quenched the
fluorescence of acrylodan-labeled actin by 37%. The binding of smooth muscle tropomyosin
to acrylodan-labeled actin resulted in an 18% increase in fluorescence (curves 3 and 4). The
fluorescence of the acrylodan-labeled actin-tropomyosin complex was also greatly quenched
by caldesmon-NBD (curves 4 and 2). Fig. 2B shows that S1 also quenched the fluorescence of
acrylodan-labeled actin. Thus while the acrylodan-modified actin gave a large signal upon
binding to caldesmon, its fluorescence was sensitive to other actin binding proteins.
The fluorescence change that occurred when caldesmon-NBD bound to acrylodan-labeled
actin was related to the fraction of actin monomers interacting with caldesmon-NBD. Fig. 3
shows the binding curve derived from the decrease in fluorescence of the actin-acrylodan as a
function of the added caldesmon-NBD. Analysis of the fluorescence data required the
assumption of a stoichiometry of binding. A reasonable fit to the data could be obtained for
any value of stoichiometry greater than 1:5; the solid curve shown is for a stoichiometry of
1:7. Two additional parameters describe binding of a large ligand to a lattice. The binding
constant for caldesmon binding to an isolated site of seven actin monomers, K, was determined
to be 3.2 × 105 M−1. The parameter for cooperativity between adjacent caldesmon molecules,
ω, was 17.9. The product Kω is the affinity of caldesmon to a site adjacent to an existing bound
caldesmon molecule; this was found to be 5.7 × 106 M−1. In our detailed earlier study, in which
the binding was measured by a more direct method, values of K and ω were typically near 6 ×
105 and 5–6, respectively, with Kωequal to 3.6 × 106 M−1 (Velaz et al., 1989). This agreement
is reasonable and suggests that the fluorescence change is monitoring the binding reaction.
Fluorescence changes accompanying the binding of IANBD-labeled caldesmon to pure actin
are shown in Fig. 4. In Fig. 4A, curves 1 and 4 show that the binding of actin to caldesmon-
NBD resulted in a 71% increase in fluorescence intensity and a small blue shift from 546 to
536 nm. The addition of a substoichiometric amount of S1 to the actin-caldesmon complex
resulted in a partial reversal of the fluorescence enhancement (curve 2); higher concentrations
of S1 totally reversed the fluorescence enhancement. This is consistent with our earlier
observation that caldesmon and S1 are competitive with each other for binding to actin. The
addition of ATP (curve 3) weakened the binding of S1 to actin and resulted in an increase in
fluorescence. This change was time-dependent, and the fluorescence returned to a low value
as the ATP was hydrolyzed and the S1 reattached to actin (not shown).
Caldesmon binds weakly to S1 (Hemric and Chalovich, 1988). Fig. 4B shows that a small
decrease in fluorescence occurred upon the addition of S1 to caldesmon-NBD in the absence
of actin. Caldesmon also binds to pure tropomyosin (Graceffa, 1987; Fujii et al, 1988; Watson
et al., 1990). Fig. 4C shows that tropomyosin caused a small (8–9%) increase in fluorescence
intensity in both the absence (curves 1 and 2) and presence (curves 3 and 4) of actin (Fig.
4C). All of these changes were much smaller than those that occurred when caldesmon-NBD
bound to actin.
Since both the NH2 and COOH ends of caldesmon-NBD contained a fluorescent label it was
necessary to determine if the observed fluorescence change was due solely to the interaction
of the COOH-terminal actin binding region with actin. The COOH- and NH2-terminal
polypeptides of IANBD-labeled caldesmon were isolated from chymotryptic digests of the
caldesmon. Amino-terminal sequence analysis of the presumptive myosin binding fragment
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indicated the presence of two polypeptides, Ser26-Tyr-Gln-Arg-Asn-Asp-Asp and Gln28-Arg-
Asn-Asp-Asp-Asp, that confirmed that this fragment is from the NH2-terminal region
containing Cys153. The addition of actin did not result in a change in the fluorescence of the
labeled NH2-terminal fragment.
The 35- and 20-kDa actin binding fragments of caldesmon, which contain only one Cys residue,
Cys580, were also purified and found to be fluorescent. Fig. 4D shows that addition of actin to
the pure IANBD-labeled 35-kDa caldesmon fragment resulted in a 92% increase in
fluorescence (curves 1 and 3). The increase in fluorescence was largely eliminated by the
addition of substoichiometric concentrations of S1 (curve 2). Therefore, the change in
fluorescence of caldesmon was due to the interaction of the COOH-terminal region of
caldesmon with actin.
We had shown earlier that modification of caldesmon with iodoacetamide does not alter its
binding to actin or actin tropomyosin (Velaz et al., 1989). Similarly, modification of the two
Cys groups of caldesmon with IANBD did not have a measurable effect on the inhibitory
activity of caldesmon (data not shown). Similarly, modification of actin with acrylodan had
little effect on the ATPase activity (data not shown). For example, at 50 mM ionic strength,
smooth muscle tropomyosin enhanced the rate of ATPase activity in the presence of acrylodan
actin and absence of caldesmon by a factor of 1.7; this is typical for unmodified actin (Williams
et al., 1984). Furthermore, more than twice as much caldesmon was required to give 50%
inhibition of the acrylodan actin-activated ATPase activity in the absence of tropomyosin.
The rate of binding of NBD-labeled caldesmon to either actin or acrylodan-labeled actin could
be readily observed in a stopped flow apparatus. Fig. 5 shows an example of a reaction using
each probe. In the cases shown, the fit was to a monoexponential function. The total
fluorescence change was completed within about 50 ms, and no further change occurred at
longer time intervals when actin bundles began to form. At higher concentrations of caldesmon,
a slightly better fit was obtained with a biexponential fit; this complexity was ignored for this
first analysis.
The analysis of the rate data to obtain the rate constants k and k′ was done by a Monte Carlo
simulation using a simple one-step binding model. For this analysis, we assumed binding
constants of caldesmon to actin in the absence and presence of tropomyosin of 0.55 × 106
M−1 and 1.9 × 106 M−1, respectively (Chen and Chalovich, 1992). These binding constants
are those to an isolated caldesmon binding site composed of seven actin monomers. The actin
lengths assumed in the simulations were M = 700,1400,2800, and 5600. The half-times of the
individual reactions were found, in simulations, to be rather insensitive to the actin length.
Thus, most of our simulations were based on M = 700 to save computing time.
Although fluorescence changes observed with caldesmon-NBD binding to pure actin reflected
changes in the caldesmon probe while binding to acrylodan actin reflected changes in the actin
probe, both measurements produced similar kinetic profiles. Fig. 6A shows the dependence on
the total caldesmon concentration of the observed half-time values for a single exponential fit
to the binding of caldesmon to pure actin. Data obtained by observing the fluorescence of
acrylodan actin (squares) were indistinguishable from those obtained by monitoring the
caldesmon-NBD fluorescence (circles). The solid curve is the result of the simulation of these
data with a single-step model having an association rate constant, k of 1 × 107 M−1 s−1 and a
dissociation rate constant, k′, of 18.2 s−1. While this was the best fit of the data, most of the
data fell within an envelope bracketed by theoretical curves with association rate constants
ranging from 0.8 to 1.2 × 107 M−1 s−1. The simple model used was a good first approximation
of the binding.
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Fig. 6B shows that the addition of tropomyosin did not greatly alter the observed kinetics of
caldesmon binding. The results of experiments done by monitoring acrylodan actin (circles)
and caldesmon-NBD (squares) were in close agreement with each other, indicating that the
same process was being monitored in each case. The profile of T½ versus caldesmon
concentration was quite similar to that obtained in the absence of smooth muscle tropomyosin.
The best fit of the simulated data was with an association rate constant of 1.2 × 107 M−1 s−1
and dissociation rate constant of 6.3 s−1, and the data were bracketed by curves generated with
association rate constants of 1 and 1.4 × 107 M−1 s−1. Interestingly, the enhanced binding of
caldesmon to actin in the presence of tropomyosin appeared to be due primarily to a decrease
in the rate constant for caldesmon detachment; the association rate constant was relatively
unchanged. The values of k and k′ that generate the best fit of half-times with experimental
points are tabulated in Table I.
DISCUSSION
Caldesmon-NBD is a useful model for studying the binding of caldesmon to actin. This probe
gave a large change in fluorescence upon binding to actin but only small changes upon binding
to myosin or tropomyosin, thus indicating a high degree of selectivity. However, observation
of this probe on caldesmon had the disadvantage of high background fluorescence when the
caldesmon-NBD concentration was high relative to actin. To overcome this difficulty, we have
also monitored acrylodan-labeled actin, which is quenched by the NBD probe on caldesmon.
Both probes left the steady state kinetics of ATP hydrolysis unaltered, and similar transient
kinetic results were obtained regardless of whether the caldesmon probe or actin probe was
monitored.
We have shown earlier that the binding of caldesmon to actin is competitive with the binding
of S1 in both the presence and absence of tropomyosin (Chalovich et al., 1987; Hemric and
Chalovich, 1988; Velaz et al., 1989, 1990; Chen and Chalovich, 1992). In agreement with that
result, we now report that the fluorescence change due to caldesmon-NBD binding to actin
was reversed by the binding of substoichiometric amounts of S1 to actin both in the presence
and absence of tropomyosin. The region of caldesmon that binds to actin and has inhibitory
activity is at the COOH-terminal domain of caldesmon (Szpacenko and Dabrowska, 1986;
Fujii et al, 1987). This region was also sufficient and necessary for the fluorescence changes
reported here.
The binding of caldesmon to actin is probably mechanistically complex because of the parking
problem that occurs for binding of a large ligand to a lattice and because of the cooperativity
that may exist among adjacent ligands. The data in the present case were analyzed by a Monte
Carlo simulation that did not include cooperative effects. The binding constants k and k′ are
intrinsic rate constants for the binding to an isolated binding site. Presumably, the true situation
consists of a series of rate constants depending on nearest neighbors and on the slower
rearrangement of sites to provide total saturation of the actin filament. However, our simple
analysis provided a reasonable approximation to the actual event as judged by the close fit of
the theoretical curve to the data of Fig. 6. Such a simple analysis would not be expected to be
suitable for a more cooperative system such as in the binding of tropomyosin to actin where
ω = 1600 (Wegner, 1979). Even in the present case, the inclusion of cooperativity would have
given a better fit of the individual reactions run at high caldesmon concentrations where there
was a slight deviation from a single exponential. We will include the effect of cooperativity in
the future.
Tropomyosin is known to enhance the binding of caldesmon to actin; this enhanced binding
appeared, from the present work, to be due to a decrease in the rate constant of dissociation of
caldesmon from actin. We did not observe any indication that tropomyosin altered the
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mechanism of binding, that is the individual time courses of the binding reaction were similar
in the presence and absence of tropomyosin; the concentration dependence of the half-times
also had a similar appearance. If there were two classes of binding sites for caldesmon, in either
the presence or absence of tropomyosin, one might expect to see biexponential binding kinetics
even at the lowest caldesmon concentrations used since the caldesmon concentration far
exceeded the number of binding sites. In actuality, we observed a good fit to the data with a
single exponential curve except at high caldesmon concentrations. While we cannot rule out
multiple sites there is no evidence from these data that they exist.
A more telling experiment would be to measure the binding with excess actin over caldesmon.
However, this becomes experimentally difficult and computationally nontrivial because
several actin monomers constitute a single binding site. Another approach is to measure the
dissociation of caldesmon from actin using the same probes described here. However, analysis
of this behavior requires Monte Carlo simulations that are different from those presented here.
This is a topic of current investigation.
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Fig. 1. Example of a typical histogram showing the total number of bound caldesmon molecules on
a single actin filament as a function of time during the first (initial) few transitions of a Monte Carlo
simulation
Each transition involves the binding or dissociation of one caldesmon molecule only.
Therefore, the number of total bound caldesmon molecules increases or decreases by one.
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Fig. 2. Fluorescence emission spectra of NBD-labeled caldesmon and acrylodan-labeled actin
Fluorescence was measured with excitation at 391 nm in a solution containing 10 mM imidazole,
pH 7.0, 2 mM MgCl2, 34 mM potassium propionate, 1 mM EGTA, and 1 mM dithiothreitol. A,
effect of caldesmon-NBD and S1 on acrylodan actin fluorescence. Curve 3 shows 1 μM
acrylodan actin alone, while curve 1 shows the effect of the addition of 1.5 mM caldesmon-
NBD. Curve 4 shows 1 μM acrylodan actin and 0.214 μM tropomyosin, while curve 2 shows the
effect of addition of 1.5 μM caldesmon-NBD. B, effect of S1 on acrylodan actin fluorescence.
Curve 2 shows 1 μM acrylodan actin, and curve 1 shows the effect of the addition of 2 μM S1.
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Fig. 3. Fluorescence titration measurement of binding of caldesmon-NBD to acrylodan actin
Fluorescence was measured at 15 °C with excitation at 391 nm in the same buffer as in Fig. 2.
The fraction of actin containing bound caldesmon was assumed to vary in a linear manner with
the fluorescence change. The free caldesmon concentration was calculated assuming a
stoichiometry of binding of 1 caldesmon/7 actin monomers. The curve shown is the best fit of
the equation of McGhee and von Hippel (1974) to the data. The parameters describing this
curve are n = 7, K = 3.2 × 105 M−1, and ω = 17.9.
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Fig. 4. Fluorescence emission spectra of NBD-labeled caldesmon
Fluorescence was measured with excitation at 492 nm with the same buffer as used in Fig. 2.
A, effect of actin and S1. Caldesmon-NBD (2 μM) is shown in curve 1. The fluorescence
increases with the addition of 10 μM actin (curve 4) and decreases again with the further
addition of 3.5 μM S1 (curve 2). Dissociation of S1 with 1 mM ATP restores the high
fluorescence (curve 3). B, effect of S1 alone. Caldesmon-NBD (1.1 μM) is shown alone (curve
1) and after the addition of 20 μM S1 (curve 2). C, effect of smooth muscle tropomyosin.
Caldesmon-NBD (1.2 μM) is shown alone (curve 2) and after the addition of 3.1 μM
tropomyosin (curve 1). A mixture of 1.2 μM caldesmon-NBD and 10 μM actin is shown in
curve 3; the small fluorescence increase that occurs with the addition of 3.1 μM tropomyosin
is shown in curve 4. D, the NBD-labeled 35-kDa, COOH-terminal caldesmon fragment (1.2
μM) is shown in curve 1. The addition of 4 μM actin increases the fluorescence (curve 3), while
the further addition of 3.4 μM S1 reverses this increase (curve 2).
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Fig. 5. Rates of fluorescence change for the binding of caldesmon-NBD with actin and acrylodan
actin
Fluorescence was measured in the same buffer as in Fig. 1 and at 15 °C. Curve A is for binding
of 0.5 μM caldesmon-NBD to 0.3 μM acrylodan actin (0.043 μM sites) and shows the decrease
in acrylodan fluorescence. The fitted curve is for a rate of 68 s−1. Curve B is for the binding of
0.45 μM caldesmon-NBD to 0.3 μM unmodified actin (0.043 μM sites) and shows the increase
in NBD fluorescence. The fitted curve is for a rate of 49 s−1.
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Fig. 6. Caldesmon concentration dependence of the half-time of binding of caldesmon-NBD to actin
(squares) and acrylodan actin (circles) in the absence (A) and presence (B) of smooth muscle
tropomyosin
Values of T½ from data such as that shown in Fig. 5 were plotted against the total caldesmon
concentration. Binding was measured at 15 °C in the same buffer used in Fig. 2. A, in the
absence of tropomyosin, the simulated curve shown is for k = 1 × 107 M−1 s−1 and k′= 18.2
s−1. B, in the presence of smooth muscle tropomyosin the simulated curve shown is for k = 1.2
× 107 M−1 s−1 and k′ = 6.3 s−1.
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Table I
Rate constants for the binding of caldesmon to actin in the presence and absence of tropomyosin
Addition k k′ K
M−1s−1 s−1 M−1
None 107 18.2 5.5 × 105
Tropomyosin 1.2 × 107 6.3 1.9 × 106
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